Skip to main content
SpringerLink
Log in

Cytokines, receptors, and inhibitors

  • Review
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

Cytokines are endogenous mediators in inflammatory and immunologic host defense reactions. In various diseases cytokines produced in excess cause systemic or local toxic effects. Cytokines therefore are tightly controlled by regulation of their biosynthesis and release and by counteracting mechanisms which limit their activities. Two new cytokine inhibitory mechanisms have recently been discovered. First, the generation of soluble receptors which compete with cellular receptors for cytokine binding has been recognized as a general phenomenon. Second, a receptor antagonist polypeptide binding to the receptor but not eliciting biological activity has been discovered in the IL-1 system. These polypeptides, when expressed in various recombinant forms, are not only research tools but may find also direct clinical use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CSF:

colony stimulating factor

TNF:

tumor necrosis factor

TNF-BP:

TNF binding protein

IL-1:

interleukin-1

IFN:

interferon

NGF:

nerve growth factor

GCSF:

granulocyte CSF

References

  1. Bendtzen K, Svenson M, Jonsson V, Hippe E (1990) Autoantibodies to cytokines — friends or foes? Immunol Today 11:167–169

    Google Scholar 

  2. Beutler B, Cerami A (1989) The biology of cachectin/TNF — a primary mediator of the host response. Annu Rev Immunol 7:625–655

    Google Scholar 

  3. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher HR (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127–3131

    Google Scholar 

  4. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670

    Google Scholar 

  5. Carter DB, Deibel MR, Dunn CJ, Tomich C-SC, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE (1990) Purification, cloning, expression and biological characterisation of an interleukin-1 receptor antagonist protein. Nature 344:633–638

    Google Scholar 

  6. Dembic Z, Loetscher HR, Gubler U, Pan Y-CE, Lahm HW, Gentz R, Brockhaus M, Lesslauer W (1990) Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231–237

    Google Scholar 

  7. DiStefano PS, Johnson EM (1988) Identification of a truncated form of the nerve growth factor receptor. Proc Natl Acad Sci USA 85:270–274

    Google Scholar 

  8. Eastgate JA, Symons JA, Duff GW (1990) Identification of an interleukin-1 beta binding protein in human plasma. FEBS Lett 260:213–216

    Google Scholar 

  9. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341–346

    Google Scholar 

  10. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D (1989) A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264:11974–11980

    Google Scholar 

  11. Engelmann H, Holtmann H, Brakebusch C, Avni SY, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D (1990) Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 265:14497–14504

    Google Scholar 

  12. Engelmann H, Novick D, Wallach D (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531–1536

    Google Scholar 

  13. Fanslow WC, Sims JE, Sassenfeld H, Morrissey PJ, Gillis S, Dower SK, Widmer MB (1990) Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 248:739–742

    Google Scholar 

  14. Fukunaga R, Seto Y, Mizushima S, Nagata S (1990) Three different mRNAs encoding human granulocyte colonystimulating factor receptor. Proc Natl Acad Sci USA 87:8702–8706

    Google Scholar 

  15. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA (1985) Stimulation of the adherence of neutrophils to umbilical vein endothel by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82:8667–8671

    Google Scholar 

  16. Girardin E, Gran GE, Dayer JM, Roux-Lombard P, The J5 Study Group, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397–400

    Google Scholar 

  17. Giri JG, Newton RC, Horuk R (1990) Identification of soluble interleukin 1 binding protein in cell free supernatants. Evidence for soluble interleukin 1 receptor. J Biol Chem 265:17416–17419

    Google Scholar 

  18. Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, Gimpel S, Cosman D, Dower SK, March CJ, Namen AE, Park LS (1990) Cloning of the human and murine interleukin-7 receptors. Demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941–951

    Google Scholar 

  19. Han J, Thompson P, Bender B (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391–394

    Google Scholar 

  20. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340

    Google Scholar 

  21. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149–1157

    Google Scholar 

  22. Hohmann H, Remy R, Brockhaus M, van Loon APGM (1989) Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264:14927–14934

    Google Scholar 

  23. Hohmann HP, Remy R, Poeschl B, van Loon APGM (1990) Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kB at low receptor occupancy and within minutes after receptor binding. J Biol Chem 265:15183–15188

    Google Scholar 

  24. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731–740

    Google Scholar 

  25. Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45–53

    Google Scholar 

  26. Lantz M, Gullberg U, Nilsson E, Olsson I (1990) Characterisation in vitro of a human tumor necrosis factor-binding protein A soluble form of a tumor necrosis factor receptor. J Clin Invest 86:1396–1402

    Google Scholar 

  27. Lebel MH, Frej BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH (1988) Dexamethasone therapy for bacterial meningitis. Results of two double-blind placebo-controlled trials. N Engl J Med 319:964–971

    Google Scholar 

  28. Lesslauer W, Tabuchi H, Gentz R, Schlaeger EJ, Brockhaus M, Grau G, Piguet PF, Pointaire P, Vassalli P, Loetscher H (1991) Bioactivity of recombinant human TNF receptor fragments. J Cell Biochem [Suppl 15F]:115

  29. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537–543

    Google Scholar 

  30. Loetscher H, Brockhaus M, Dembic Z, Gentz R, Gubler U, Hohmann HP, Lahm HW, van Loon APGM, Pan Y-CE, Schlaeger EJ, Steinmetz M, Tabuchi H, Lesslauer W (1991) Two distinct tumor necrosis factor receptors — members of a new cytokine receptor gene family. Oxf Surv Eukaryot Genes 7:119–142

    Google Scholar 

  31. Loetscher HR, Pan YE, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the 55kd tumor necrosis factor receptor. Cell 61:351–360

    Google Scholar 

  32. Maliszewski CR, Fanslow WC (1990) Soluble receptors for IL-1 and IL-4. Biological activity and therapeutic potential. Trends Biotechnol 8:324–329

    Google Scholar 

  33. Mazzei GJ, Seckinger PL, Dayer JM, Shaw AR (1990) Purification and characterisation of a 26 kDa competitive inhibitor of interleukin 1. Eur J Immunol 20:683–689

    Google Scholar 

  34. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL (1991) Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173:931–939

    Google Scholar 

  35. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Parks LS (1989) The murine interleukin-4 receptor. Molecular cloning and characterisation of secreted and membrane-bound forms. Cell 59:335–348

    Google Scholar 

  36. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Bender B, McCracken GH (1989) Correlation of interleukin-lbeta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 115:208–213

    Google Scholar 

  37. Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A (1989) Tumor necrosis factor alpha in infectious meningitis. Arch Dis Childhood 64:1274–1279

    Google Scholar 

  38. Novick D, Engelmann H, Wallach D, Rubinstein M (1989) Soluble cytokine receptors are present in normal human urine. J Exp Med 170:1409–1414

    Google Scholar 

  39. Novick D, Engelmann H, Wallach D, Revel M, Rubinstein M (1990) Purification of soluble cytokine receptors from normal human urine by ligand affinity and immunoaffinity chromatography. J Chromatogr 510:331–337

    Google Scholar 

  40. Olsson I, Lantz M, Nilsson E, Peetre C, Thyself H, Grubb A, Adolf G (1989) Isolation and characterisation of a tumor necrosis factor binding protein from urine. Eur J Haematol 42:270–275

    Google Scholar 

  41. Peetre C, Thyself H, Grubb A, Olsson I (1988) A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 41:414–419

    Google Scholar 

  42. Porteu F, Nathan C (1990) Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172:599–607

    Google Scholar 

  43. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172–3177

    Google Scholar 

  44. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173:699–703

    Google Scholar 

  45. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361–370

    Google Scholar 

  46. Seckinger P, Isaaz S, Dayer JM (1988) A human inhibitor of tumor necrosis factor alpha. J Exp Med 167:1511–1516

    Google Scholar 

  47. Seckinger P, Vey E, Turcatti G, Wingfield P, Dayer JM (1990a) Tumor necrosis factor inhibitor. Purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities. Eur J Immunol 20:1167–1174

    Google Scholar 

  48. Seckinger P, Zhang JH, Hauptmann B, Dayer JM (1990b) Characterisation of a tumor necrosis factor alpha (TNF alpha) inhibitor. Evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Sci USA 87:5188–5192

    Google Scholar 

  49. Shih YJ, Baynes RD, Hudson BG, Flowers CH, Skikne BS, Cook JD (1990) Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem 265:19077–19081

    Google Scholar 

  50. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023

    Google Scholar 

  51. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573–581

    Google Scholar 

  52. Takaki S, Tominaga A, Hitoshi Y, Mita S, Sonoda E, Yamaguchi N, Takatsu K (1990) Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J 9:4367–4374

    Google Scholar 

  53. Waage A, Halstensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet I, pp 355–357

    Google Scholar 

  54. Zabel P, Wolter DT, Schonharting MM, Schade UF (1989) Oxipentifylline in endotoxaemia. Lancet II, pp 1474–1477

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung PRTB, F. Hoffmann-LaRoche, Ltd., CH-4002, Basel, Schweiz, Germany

    G. Gehr, T. Braun &  W. Lesslauer

Authors
  1. G. Gehr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Lesslauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gehr, G., Braun, T. & Lesslauer, W. Cytokines, receptors, and inhibitors. Clin Investig 70, 64–69 (1992). https://doi.org/10.1007/BF00422944

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00422944

Key words

Search

Navigation